651
Participants
Start Date
May 31, 2002
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
microsatellite instability analysis
Memorial Sloan-Kettering Cancer Center, New York
James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester
UPMC Cancer Center at Magee-Womens Hospital, Pittsburgh
Western Pennsylvania Hospital, Pittsburgh
Abington Memorial Hospital, Abington
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore
St. Agnes Cancer Center, Baltimore
INOVA Fair Oaks Hospital, Fairfax
Duke Comprehensive Cancer Center, Durham
Presbyterian Hospital, Charlotte
Surgical Oncology of Northeast Georgia, Gainesville
Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, Fort Lauderdale
Morton Plant Hospital, Clearwater
Providence Cancer Center, Mobile
Baptist Hospital, Nashville
Baptist Cancer Institute at Baptist Memorial Hospital - Memphis, Memphis
Digestive Health Specialists, P.A., Tupelo
Cleveland Clinic Taussig Cancer Center, Cleveland
Akron General's McDowell Cancer Center, Akron
Indiana University Cancer Center, Indianapolis
Great Lakes Cancer Institute - McLaren, Flint
John Stoddard Cancer Center at Iowa Methodist Medical Center, Des Moines
Froedtert Memorial Lutheran Hospital, Milwaukee
Medical College of Wisconsin Cancer Center, Milwaukee
Appleton Medical Center, Appleton
University of Minnesota Cancer Center, Minneapolis
Northwest Community Hospital, Arlington Heights
Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood
Siteman Cancer Center at Barnes-Jewish Hospital, St Louis
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia
Ochsner Clinic Foundation, New Orleans
Integris Oncology Services, Oklahoma City
Natalie Warren Bryant Cancer Center, Tulsa
Presbyterian Hospital of Dallas, Dallas
Baylor University Medical Center, Dallas
Methodist Hospital, Houston
Huntsman Cancer Institute, Salt Lake City
UCSF Comprehensive Cancer Center, San Francisco
Associated Surgeons P.S., Spokane
Sacred Heart Medical Center, Spokane
Providence Cancer Center at Holy Family Hospital, Spokane
Mobile Infirmary Medical Center, Mobile
Arrowhead Regional Medical Center, Colton
City of Hope Comprehensive Cancer Center, Duarte
Shands Cancer Center at the University of Florida Health Science Center, Gainesville
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Rush Copley Medical Center, Aurora
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
University of Chicago Cancer Research Center, Chicago
Holden Comprehensive Cancer Center at University of Iowa, Iowa City
Central Baptist Hospital, Lexington
Louisiana State University Health Sciences Center - Shreveport, Shreveport
Brigham and Women's Hospital, Boston
Lahey Clinic Medical Center - Burlington, Burlington
UMASS Memorial Cancer Center - University Campus, Worcester
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha, Omaha
Cancer Center at Creighton University Medical Center, Omaha
Blumenthal Cancer Center at Carolinas Medical Center, Charlotte
Comprehensive Cancer Center at Wake Forest University, Winston-Salem
Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, Philadelphia
Allegheny General Hospital, Pittsburgh
Sarah Cannon Cancer Center at Parkridge Medical Center, Chattanooga
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville
University of Texas - MD Anderson Cancer Center, Houston
Fletcher Allen Health Care - Medical Center Campus, Burlington
Inova Fairfax Hospital, Falls Church
Massey Cancer Center at Virginia Commonwealth University, Richmond
Deaconess Medical Center, Spokane
Fox Valley Surgical Associates at Appleton Medical Center, Appleton
University of Wisconsin Comprehensive Cancer Center, Madison
Regional Cancer Care at Thunder Bay Regional Health Sciences Centre, Thunder Bay
Toronto Sunnybrook Regional Cancer Centre, Toronto
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER